VTAK (Catheter Precision, Inc.) Stock Analysis - AI Report
Catheter Precision, Inc. (VTAK) is a publicly traded Healthcare sector company. As of May 21, 2026, VTAK trades at $0.80 with a market cap of $2.23M and a P/E ratio of -0.05. VTAK moved -3.83% today. Year to date, VTAK is -61.62%; over the trailing twelve months it is -85.28%. Its 52-week range spans $0.75 to $33.06. Rallies surfaces VTAK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on VTAK?
Rallies AI research for VTAK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
COLOMBATTO MARTIN J sold 3 (~$1.201) on Jan 29, 2025.
JENKINS DAVID A bought 9.53K (~$5.69K) on Jan 23, 2024.
JENKINS DAVID A bought 9.53K (~$4.09K) on Jan 22, 2024.
VTAK Analyst Consensus
VTAK analyst coverage data. Average price target: $0.00.
Common questions about VTAK
What is the AI research view on VTAK?
Rallies AI research for VTAK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for VTAK?
Rallies AI research for VTAK combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is VTAK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VTAK. It does not provide personalized investment advice.
